Mutual interaction and reciprocal down-regulation between c-met and insulin receptor substrate-1

Journal of Cellular Physiology

Volumn 224, Issue 3, 2010, Pages 658-663

  DeAngelis, Tiziana ^a   Morrione, Andrea ^a   Baserga, Renato ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1; PROTEIN P85; SCATTER FACTOR RECEPTOR; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL LYSATE; CELL MOTILITY; CELL PROLIFERATION; CELL STIMULATION; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; IMMUNOPRECIPITATION; METASTASIS; MITOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; CELL LINE; CELL MOVEMENT; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; HEPATOCYTE GROWTH FACTOR; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; MICE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION;

EID: 77954568158     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22164     Document Type: Article

References (53)

1. Baserga R. 2000. The contradictions of the insulin-like growth factor 1 receptor. Oncogene 19:5574-5581.
2. Baserga R. 2009. The insulin receptor substrate-1: A biomarker for cancer? Exp Cell Res 315:727-732.
3. Belletti B, Prisco M, Morrione A, Valentinis B, Navarro M, Baserga R. 2001. Regulation of Id2 gene expression by the IGF-1 receptor requires signaling by phosphatidylinositol-3 kinase. J Biol Chem 276:13867-13874. (Pubitemid 37391766)
4. Benvenuti S, Comoglio P. 2007. The MET receptor tyrosine kinase in invasion and metastases. J Cell Physiol 213:316-325. (Pubitemid 47509708)
5. Beviglia L, Matsumoto K, Lion CS, Ziober BL, Kramer RH. 1997. Expression of the c-met/HGF receptor in human breast carcinoma: Correlation with tumor progression. Int J Cancer 74:301-309. (Pubitemid 27321800)
6. Boylan JM, Gruppuso PA. 2002. Insulin receptor substrate-1 is present in hepatocyte nuclei from intact rats. Endocrinology 143:4178-4183.
7. Bruning JC, Winnay J, Cheatham B, Kahn CR. 1997. Differential signaling by insulin receptor substrate-1 (IRS-1) and IRS-2 in IRS-1-deficient cells. Mol Cell Biol 17:1513-1521. (Pubitemid 27097381)
8. Castles GC, Fuqua SA, Klotz DM, Hill SM. 1993. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT20 human breast cancer cell line. Cancer Res 53:5934-5939. (Pubitemid 24006163)
9. Cesarone G, Garofalo C, Abrams MT, Igoucheva O, Alexeev V, Yoon K, Surmacz E, Wickstrom E. 2006. RNAi-mediated silencing of insulin receptor substrate-1 (IRS-1) enhances tamoxifen-induced cell death in MCF-7 breast cancer cells. J Cell Biochem 98:440-450.
10. Chang Q, Li Y, White MF, Fletcher JA, Xiao S. 2002. Constitutive activation of insulin receptor substrate-1 is a frequent event in human tumors: Therapeutic implications. Cancer Res 62:6035-6038. (Pubitemid 35244449)
11. Chen J, Wu A, Sun H, Drakas R, Garofalo C, Cascio S, Surmacz E, Baserga R. 2005. Functional significance of type 1 insulin-like growth factor-mediated nuclear translocation of the insulin receptor substrate-1 and b-catenin. J Biol Chem 280:29912-29920. (Pubitemid 41177069)
12. Chen J, Capozza F, Wu A, DeAngelis T, Sun H, Lisanti M, Baserga R. 2008. Regulation of insulin receptor substrate-1 levels by caveolin 1. J Cell Physiol 217:281-289.
13. Cristofanelli B, Valentinis B, Soddu S, Rizzo MG, Marchetti A, Bossi G, Morena AR, Dews M, Baserga R, Sacchi A. 2000. Co-operative transformation of 32D cells by the combined expression of IRS-1 and v-Ha-Ras. Oncogene 19:3245-3255. (Pubitemid 30487411)
14. D'Ambrosio C, Keller SR, Morrione A, Lienhard GE, Baserga R, Surmacz E. 1995. Transforming potential of the insulin receptor substrate-1. Cell Growth Diff 6:557-562.
15. Dalmizrak O, Wu A, Chen J, Sun H, Utama FE, Zambelli D, Tran TH, Rui H, Baserga R. 2007. The insulin receptor substrate-1 regulates the transformed phenotype of BT-20 human mammary cancer cells. Cancer Res 67:2124-2130. (Pubitemid 46424231)
16. DeAngelis T, Chen J, Wu A, Prisco M, Baserga R. 2006. Transformation by the Simian Virus 40 T antigen is regulated by IGF-1 receptor and IRS-1 signaling. Oncogene 25:32-42. (Pubitemid 43050001)
17. Dearth RK, Cui X, Kim HJ, Kuiatse I, Lawrence NA, Zhang X, Divisova J, Britton OL, Mohsin S, Allred DC, Hadsell DL, Lee AV. 2006. Mammary tumorigenesis and metastasis caused by overexpression of the insulin receptor substrate-1 (IRS-1) or IRS-2. Mol Cell Biol 26:9302-9314.
18. Del Rincon SV, Rousseau C, Samanta R, Miller WH. 2003. Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI3-kinae/Akt pathway. Oncogene 22:3353-3360.
19. Del Rincon SV, Guo Q, Morelli C, Shiu HY, Surmacz E, Miller WH. 2004. Retinoic acid mediates degradation of IRS-1 by the ubiquitin-proteasome pathway, via a PKC-dependent mechanism. Oncogene 23:9269-9279.
20. Economu MA, All-Ericsson C, Bykov V, Girnita L, Bartoluzzi A, Larsson O, Seregard S., 2005. Receptors of the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: Intercorrelation and prognostic implications. Invest Ophthalmol Vis Sci 46:4372-4375.
21. Gibson SL, Ma Z, Shaw LM. 2007. Divergent roles for IRS-1 and IRS-2 in breast cancer metastasis. Cell Cycle 6:631-637.
22. Goel HL, Fornaro M, Moro L, Teider N, Rhim JS, King M, Languino LR. 2004. Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by b1 integrins. J Cell Biol 166:407-418.
23. Hiscox S, Jordan NJ, Jiang W, Harper M, McClelland R, Smith C, Nicholson RJ. 2006. Chronic exposure to fulvestrant promotes over-expression of the c-met receptor in breast cancer cells: Implications for tumour-stroma interaction. Endocrine-related Cancer 13:1085-1099.
24. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE. 2000. The effects of insulin-like growth factors on tumorigenesis and neoplastic growths. Endocrine Rev 21:215-244.
25. Kim B, van Golen M, Feldman EL. 2004. Insulin like growth factor-1 signaling in human neuroblastoma cells. Oncogene 23:130-141.
26. Lannon CL, Martin MJ, Tognon CE, Jin W, Kim SJ, Sorensen PHB. 2004. A highly conserved NTRK3 C-terminal sequence in the ETV6-NTRK3 oncoprotein binds the phosphotyrosine binding domain of insulin receptor substrate-1. J Biol Chem 279:6225-6234.
27. LaRocca G, Badin M, Shi B, Xiu SQ, DeAngelis T, Sepp-Lorenzino L, Baserga R. 2009a. Mechanism of growth inhibition by microRNA 145: The role of the IGF-1 receptor signaling pathway. J Cell Physiol 220:485-491.
28. LaRocca G, Shi B, Badin M, DeAngelis T, Sepp-Lorenzino L, Baserga R. 2009b. Growth inhibition by microRNAs that target the insulin receptor substrate-1. Cell Cycle 8:2255-2259.
29. Li J, YenC, Liaw D, PodsypaninaK, Bose S, Wang SI, Ouc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann C, Tycko B, Hibshoosh H, Wigler MH, Parsons R. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 275:1943-1947.
30. Li J, Simpson L, Takahashi M, Miliaresis C, Myers MP, Tonks N, Parsons R. 1998. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the Akt/Protein Kinase B oncogene. Cancer Res 58:5667-5672.
31. Ma Z, Gibson SL, Byrne MA, Zhang J, White M, Shaw LM. 2006. Suppression of insulin receptor substrate-1 (IRS-1) promotes mammary tumor metastasis. Mol Cell Biol 26:9338-9351.
32. Maina F, Pante' G, Helmbacher F, Andrea R, Prthin A, Davies AM, Ponzetto C, Klein R. 2001. Coupling met to specific pathways results in distinct developmental outcomes. Mol Cell 7:1293-1306.
33. Miller CT, Lin L, Casper AM, Lim J, Thomas DG, Orringer MB, Chang AC, Chambers QAF, Giordano TJ, Glover TW, Beer DG. 2006. Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal carcinoma. Oncogene 25:409-418.
34. Morrison KB, Tognon CE, Garnett MJ, Deal C, Sorensen PHB. 2002. ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation. Oncogene 21:5684-5695. (Pubitemid 35333001)
35. Myers MG, Jr., Grammer TC, Wang LM, Sun XJ, Pierce JH, Blenis J, White MF. 1994. Insulin receptor substrate-1 mediates phosphatidykinositol 3'-kinase and p70S6K signaling during insulin, insulin-like growth factor-1 and interleukin-4 stimulation. J Biol Chem 269:28783-28789.
36. O'Connor R. 2003. Regulation of IGF-1 receptor signaling in tumor cells. Horm Metab Res 35:771-777. (Pubitemid 38058182)
37. Ponzetto C, Bardelli A, Zhen Z, Maina F, Dalla Zonca P, Giordano S, Graziani A, Panayotou G, Comoglio PM. 1994. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 77:261-271.
38. Reiss K, Valentinis B, Tu X, Xu SQ, Baserga R. 1998. Molecular markers of IGF-1-mediated mitogenesis. Exp Cell Res 242:361-372.
39. Reiss K, Wang JY, Romano G, Furnari FB, Cavenee WK, Morrione A, Tu X, Baserga R. 2000. IGF-1 receptor signaling in a prostate cancer cell line with a PTEN mutation. Oncogene 19:2687-2694. (Pubitemid 30326418)
40. Reiss K, Wang JY, Romano G, Tu X, Peruzzi F, Baserga R. 2001. Mechanism of regulation of cell adhesion and motility by insulin receptor substrate-1 in prostate cancer cells. Oncogene 20:490-500. (Pubitemid 32158229)
41. Ronen D, Altstock RT, FironM,Mittelman L, Sobe T, Resau JH, Vande Woude GF, Tsarfaty I. 1999. Met-HGF/SF mediates growth arrest and differentiation in T47D breast cancer cells. Cell Growth Diff 10:131-140. (Pubitemid 29093925)
42. Rubini M, Hongo A, D'Ambrosio C, Baserga R. 1997. The IGF-1 receptor in mitogenesis and transformation of mouse embryo cells: Role of receptor number. Exp Cell Res 230:284-292. (Pubitemid 27190648)
43. Sell C, Rubini M, Rubin R, Liu JP, Efstratiadis A, Baserga R. 1993. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type-1 IGF receptor. Proc Natl Acad Sci USA 90:11217-11221.
44. Shi B, Sepp-Lorenzino M, Prisco M, Linsley P, DeAngelis T, Baserga R. 2007. Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J Biol Chem 282:32582-32590. (Pubitemid 350159311)
45. Soon L, Flechner L, Gutkind JS, Wang LH, Baserga R, Pierce JH, LiW. 1999. Insulin-like growth factor 1 synergizes with Interleukin 4 for hematopietic cell proliferation independent of insulin receptor substrate expression. Mol Cell Biol 19:3816-3828.
46. Sun H, Baserga R. 2008. The role of insulin receptor substrate-1 in transformation by v-src. J Cell Physiol 215:725-732. (Pubitemid 351632694)
47. Tanaka S, Mohr L, Schmidt EV, Sugimachi K, Wands JR. 1997. Biological effects of insulin receptor substrate-1 overexpression in hepartocytes. Hepatology 26:598-604. (Pubitemid 27392349)
48. Tsarfaty I, Resau JH, Rulong S, Jeydar I, Faletto DL, Wande Woude GF. 1992. The met proto-oncogene receptor and lumen formation. Science 257:1258-1261.
49. Valentinis B, Romano G, Peruzzi F, Morrione A, Prisco M, Soddu S, Cristofanelli B, Sacchi A, Baserga R. 1999. Growth and differentiation signals by the insulin-like growth factor 1 receptor in hemopoietic cells are mediated through different pathways. J Biol Chem 274:12423-12430. (Pubitemid 129518006)
50. Valentinis B, Navarro M, Zanocco-Marani T, Edmonds P, McCormick J, Morrione A, Sacchi A, Romano G, Reiss K, Baserga R. 2000. Insulin receptor substrate-1, p70S6K and cell size in transformation and differentiation of hemopoietic cells. J Biol Chem 275:25451-25459.
51. Wu A, Tu X, Prisco M, Baserga R. 2005. Regulation of upstream binding factor 1 activity by insulin-like growth factor 1 receptor signaling. J Biol Chem 280:2863-2872. (Pubitemid 40189395)
52. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, LeRoith D. 1999. Normal growth and development in the absence of hepatic insulin-like growth factor-1. Proc Natl Acad Sci 96:7324-7329.
53. Zumkeller W. 2003. IGFs and epithelial cancer. In: LeRoith D, Zumkeller W, Baxter RC, editors. Insulin-like growth factors. Georgetown, TX: Landes Bioscience. pp. 399-409.